Your browser doesn't support javascript.
loading
A Mutant Methionyl-tRNA Synthetase-Based toolkit to assess induced-Mesenchymal Stromal Cell secretome in mixed-culture disease models.
Burgess, Jeremy D; Amerna, Danilyn; Norton, Emily S; Parsons, Tammee M; Perkerson, Ralph B; Faroqi, Ayman H; Wszolek, Zbigniew K; Cazares, Hugo Guerrero; Kanekiyo, Takahisa; Delenclos, Marion; McLean, Pamela J.
Affiliation
  • Burgess JD; Mayo Clinic Graduate School of Biomedical Sciences.
  • Amerna D; Mayo Clinic Jacksonville Campus: Mayo Clinic in Florida.
  • Norton ES; Mayo Clinic Graduate School of Biomedical Sciences.
  • Parsons TM; Mayo Clinic Jacksonville Campus: Mayo Clinic in Florida.
  • Perkerson RB; Mayo Clinic Jacksonville Campus: Mayo Clinic in Florida.
  • Faroqi AH; Mayo Clinic Graduate School of Biomedical Sciences.
  • Wszolek ZK; Mayo Clinic in Florida Department of Neurology and Neurosurgery.
  • Cazares HG; Mayo Clinic in Florida Department of Neurology and Neurosurgery.
  • Kanekiyo T; Mayo Clinic Jacksonville Campus: Mayo Clinic in Florida.
  • Delenclos M; Mayo Clinic Jacksonville Campus: Mayo Clinic in Florida.
  • McLean PJ; Mayo Clinic Jacksonville Campus: Mayo Clinic in Florida.
Res Sq ; 2023 May 03.
Article de En | MEDLINE | ID: mdl-37205579
ABSTRACT
Background Mesenchymal stromal cells (MSCs) have a dynamic secretome that plays a critical role in tissue repair and regeneration. However, studying the MSC secretome in mixed-culture disease models remains challenging. This study aimed to develop a mutant methionyl-tRNA synthetase-based toolkit (MetRS L274G ) to selectively profile secreted proteins from MSCs in mixed-culture systems and demonstrate its potential for investigating MSC responses to pathological stimulation. Methods We used CRISPR/Cas9 homology-directed repair to stably integrate MetRS L274G into cells, enabling the incorporation of the non-canonical amino acid, azidonorleucine (ANL), and facilitating selective protein isolation using click chemistry. MetRS L274G was integrated into both in H4 cells and induced pluripotent stem cells (iPSCs) for a series of proof-of-concept studies. Following iPSC differentiation into induced-MSCs, we validated their identity and co-cultured MetRS L274G -expressing iMSCs with naïve or lipopolysaccharide- (LPS) treated THP-1 cells. We then profiled the iMSC secretome using antibody arrays. Results Our results showed successful integration of MetRS L274G into targeted cells, allowing specific isolation of proteins from mixed-culture environments. We also demonstrated that the secretome of MetRS L274G -expressing iMSCs can be differentiated from that of THP-1 cells in co-culture, and is altered when co-cultured with LPS-treated THP-1 cells compared to naïve THP-1 cells. Conclusions The MetRS L274G -based toolkit we have generated enables selective profiling of the MSC secretome in mixed-culture disease models. This approach has broad applications for examining not only MSC responses to models of pathological conditions, but any other cell type that can be differentiated from iPSCs. This can potentially reveal novel MSC-mediated repair mechanisms and advancing our understanding of tissue regeneration processes.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Sq Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Sq Année: 2023 Type de document: Article